Insider · CIK 0001388000

Noble James

Reports to the SEC for 5 companies · BRANFORD, CT

sec.gov

Transactions

Companies

Filings

CIK

0001388000

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.4K sh	—	—	0
2025-02-13	LAVA Therapeutics NVCommon Shares (Right to Buy)A Award	Director	AAward	+33.4K sh	—	—	33,390
2022-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+711K sh	—	—	710,711
2021-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+380K sh	—	—	379,788
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−18.6K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−9,168 sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−17.7K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10.7K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−16.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−9,432 sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−34.4K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCD Disposition to Issuer	Director	DDisposition to Issuer	−27.5K sh	—	—	0
2021-02-22	GW PHARMACEUTICALS PLCShare OptionsA Award	Director	AAward	+22.5K sh	—	—	22,464
2020-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+180K sh	—	—	179,785
2020-06-04	GW PHARMACEUTICALS PLCShare OptionsA Award	Director	AAward	+34.4K sh	—	—	34,416
2020-05-29	ADAPAdaptimmune Therapeutics PLCS Sale	Director	SSale	−500K sh	$9.33	−$4.67M	0
2020-04-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+31K sh	—	—	31,000
2020-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Director	SSale	−100K sh	$4.00	−$400K	0
2020-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Director	SSale	−200K sh	$5.00	−$1M	0
2019-05-24	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director	MExercise/Conversion	+14.5K sh	$0.00	+$18.823	41,979
2019-05-24	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−14.5K sh	—	—	0
2019-05-24	GW PHARMACEUTICALS PLCS Sale	Director	SSale	−13.8K sh	$15.58	−$215K	27,500
2019-05-24	GW PHARMACEUTICALS PLCS Sale	Director	SSale	−3,600 sh	$15.49	−$55.8K	41,300
2019-05-24	GW PHARMACEUTICALS PLCS Sale	Director	SSale	−10.2K sh	$15.32	−$156K	44,900
2019-05-24	GW PHARMACEUTICALS PLCS Sale	Director	SSale	−41.8K sh	$15.26	−$638K	55,100
2019-05-24	GW PHARMACEUTICALS PLCS Sale	Director	SSale	−13.2K sh	$15.17	−$200K	96,896
2019-05-24	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director	MExercise/Conversion	+68.1K sh	$4.86	+$331K	110,096
2019-05-24	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−34.1K sh	—	—	5
2019-05-24	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−34.1K sh	—	—	0
2019-05-16	ADAPAdaptimmune Therapeutics PLCM Exercise/Conversion	Director	MExercise/Conversion	+1.77M sh	$0.14	+$254K	1,773,100
2019-03-01	GW PHARMACEUTICALS PLCStock OptionsA Award	Director	AAward	+3,144 sh	—	—	3,144
2019-03-01	GW PHARMACEUTICALS PLCStock OptionsA Award	Director	AAward	+3,144 sh	—	—	3,144
2019-03-01	GW PHARMACEUTICALS PLCStock OptionsA Award	Director	AAward	+16.5K sh	—	—	16,548
2019-03-01	GW PHARMACEUTICALS PLCStock OptionsA Award	Director	AAward	+3,144 sh	—	—	3,144
2019-01-04	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+562K sh	—	—	561,792
2019-01-04	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+2.52M sh	—	—	2,515,536
2018-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+384K sh	—	—	384,120
2018-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+1.72M sh	—	—	1,719,936
2017-01-13	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+2.07M sh	—	—	2,072,976
2016-01-18	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+1.97M sh	—	—	1,968,016
2012-01-05	SSKNSTRATA Skin Sciences, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2009-10-01	CURAGEN CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2009-10-01	CURAGEN CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2009-10-01	CURAGEN CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2009-10-01	CURAGEN CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2009-10-01	CURAGEN CORPD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2009-10-01	CURAGEN CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,667 sh	—	—	0
2009-10-01	CURAGEN CORPD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2009-05-13	CURAGEN CORPStock Option (Right to Buy)A Award	Director	AAward	+1,667 sh	$1.00	+$1,667	1,667

Recent filings

Accepted (ET)
Nov 174
Noble James0001388000-25-000005
SEC(opens sec.gov)
Feb 184
Noble James0001415889-25-004530
SEC(opens sec.gov)
Jul 14
Noble James0001104659-22-076897
SEC(opens sec.gov)
Jul 24
Noble James0001104659-21-088969
SEC(opens sec.gov)
May 74
Noble James0000899243-21-018665
SEC(opens sec.gov)
Feb 244
Noble James0000899243-21-008083
SEC(opens sec.gov)
Jul 14
Noble James0001104659-20-079787
SEC(opens sec.gov)
Jun 84
Noble James0000899243-20-015699
SEC(opens sec.gov)
Jun 24
Noble James0001104659-20-069142
SEC(opens sec.gov)
Apr 14
Noble James0001104659-20-042013
SEC(opens sec.gov)
Jan 154
Noble James0001104659-20-004419
SEC(opens sec.gov)

Companies

Address

322 EAST MAIN STREET

BRANFORD, CT, 06405